一种基于代谢物的抗疟疾机制.
bioRxiv : the preprint server for biology
|March 10, 2025
概括
黄是由胆红素积累引起的,是对疟疾的保护性反应. 在无症状感染中,高 bilirubin 水平限制了寄生虫的生长,并降低了疟疾死亡率.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
背景情况:
- 黄是一种常见的疟疾症状,与胆红素积累有关.
- 黄在Plasmodium感染中的适应性作用尚不清楚.
研究的目的:
- 为了研究 bilirubin 在疟疾病原发生中的作用.
- 为了确定黄是否是对Plasmodium感染的保护性或有害宿主反应.
主要方法:
- 在无症状和有症状的疟疾患者中的比利鲁宾水平的比较分析.
- 在疟疾小鼠模型中对胆红素合成和结合途径的基因操纵.
- 在体外研究评估非结合性胆红素对Plasmodium falciparum扩散和寄生虫器官功能的影响.
主要成果:
- 与症状性疟疾相比,无症状的Plasmodium falciparum感染显示出非结合性胆红素与寄生虫负担的比率显著更高.
- 基因抑制胆红素合成 (BVRA) 在小鼠中加剧了疟疾毒性和死亡率.
- 抑制肝胆红素结合 (UGT1A1) 在小鼠中提供了对疟疾的保护.
- 未结合的胆红素通过抑制线粒体金字素合成来抑制红细胞中的Plasmodium falciparum生长.
- 未结合的 bilirubin 破坏了血红素结晶,并损害了寄生虫的食物真空.
结论:
- 黄,以未结合的胆红素积累为特征,是对Plasmodium感染的适应性代谢反应.
- 这种反应通过抑制寄生虫的增殖和破坏重要的寄生虫过程来限制疟疾的严重程度.
更多相关视频
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.2K
09:25CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
9.9K
相关概念视频
Symbiosis
27.2K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
27.2K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
